10 Results for "

h-CM

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "h-CM" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-139465
CAS No.: 2364554-48-1
Purity:  99.86%
Synonyms: CK-274; CK-3773274
Target:  

Myosin

Research Areas:  

Cardiovascular Disease

Aficamten (CK-274) is a potent cardiac myosin inhibitor with an IC50 of 1.4 μM. Aficamten can be used for the research of hypertrophic cardiomyopathy (HCM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-133897
CAS No.: 26988-72-7
Purity:  99.18%
Synonyms: 1-Methyl-DL-tryptophan; (Rac)-NLG-8189
(Rac)-Indoximod (1-Methyl-DL-tryptophan) is an indoleamine 2,3-dioxygenase (IDO) inhibitor. Co-treatment with IFN-γ and (Rac)-Indoximod markedly reduces the activity of human cardiac myofibroblasts (hCMs) expressing α-SMA and induces apoptosis through up-regulating the IRF-1, Fas, and FasL genes .
loading...
    loading...
Cat. No.: HY-128326
CAS No.: 2362525-64-0
Target:  

MAP3K

Research Areas:  

Cardiovascular Disease

ZAK-IN-1 is an orally active and selective selective leucine-zipper and sterile‑α motif kinase (ZAK) inhibitor with IC50 of 4 nM and KD of 8 nM. ZAK-IN-1 exhibits excellent selectivity against a panel of 403 wild-type kinases. ZAK-IN-1 blocks p38/GATA-4 and JNK/c-Jun signaling and shows promising anti antihypertrophic cardiomyopathy (HCM) efficacy. ZAK-IN-1 can be used for the study of HCM .
loading...
    loading...
Cat. No.: HY-148852
CAS No.: 282536-25-8
Target:  

HSV

Research Areas:  

Infection

PNU-183792, a 4-oxo-dihydroquinoline, is an orally active HSV polymerases inhibitor. PNU-183792 shows a broad-spectrum antiviral activity, with IC50 values of 0.69 μM, 0.37 μM and 0.58 μM for human cytomegalovirus (HCM), varicella zoster virus and HSV polymerases, respectively. PNU-183792 is inactive against human α, γ and δ polymerases. PNU-183792 also inhibits simian varicella virus (SVV), murine cytomegalovirus (MCMV) and rat cytomegalovirus (RCMV) .
loading...
    loading...
Cat. No.: HY-114793
CAS No.: 748816-43-5
Research Areas:  

Endocrinology

AL-12180 is a potent and selective FP-receptor agonist with a Ki of 143 nM. AL-12180 stimulates the mobilization of intracellular Ca 2+ in h-TM and h-CM cells with EC50s of 111 and 11 nM, respectively .
loading...
    loading...
Cat. No.: HY-176850
CAS No.: 2770280-70-9
Target:  

Myosin

Research Areas:  

Cardiovascular Disease

Myosin-IN-2 (Example 16) is a Myosin ATPase inhibitor with a IC50 of 1.06  μM. Myosin-IN-2 can be used for heart diseases like hypertrophic cardiomyopathy (HCM) research .
loading...
    loading...
Cat. No.: HY-125641A
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

AL-34662 (formate) is a 5-HT2 receptor agonist (IC50: 0.8-1.5 nM). AL-34662 (formate) stimulates inositol phosphate turnover and Ca 2+ release in human ciliary muscle cells (h-CM) (E50: 289 nM) and human trabecular meshwork cells (h-TM) (E50: 254 nM). AL-34662 (formate) can be used in studies to lower intraocular pressure (IOP) .
loading...
    loading...
Cat. No.: HY-183588
CAS No.: 2117631-52-2
Research Areas:  

Neurological Disease

HCM-01 is an Excitatory amino acid transporter 2 (EAAT2) activator with oral effectiveness and blood-brain barrier penetration.HCM-01 binds to the allosteric site of EAAT2, increases EAAT2 expression in astrocytes, enhances glutamate-handling capacity, and modulates glutamate homeostasis.HCM-01 acts as an antioxidant, improves oxidative/antioxidative balance and increases total antioxidant capacity. HCM-01 can be used for the research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-W759845
Synonyms: CK-274-d3; CK-3773274-d3
Aficamten-d3 (CK-274-d3) is deuterium labeled Aficamten. Aficamten (CK-274) is a potent cardiac myosin inhibitor with an IC50 of 1.4 μM. Aficamten can be used for the research of hypertrophic cardiomyopathy (HCM) .
loading...
    loading...
Cat. No.: HY-17681
CAS No.: 2839464-02-5
Target:  

Myosin

Research Areas:  

Cardiovascular Disease

Myosin-IN-5 (example 3) is a selective cardiac myosin inhibitor with an IC50 of 1.5 μM. Myosin-IN-5 shows much less effective in inhibiting skeletal myofibril activity (IC50 of 43.4 μM). Myosin-IN-5 can be used for the study of hypertrophic cardiomyopathy (HCM) and cardiac diseases .
loading...
    loading...